tiprankstipranks
Sanofi (GB:0O59)
LSE:0O59
Holding GB:0O59?
Track your performance easily

Sanofi (0O59) Share Forecast & Price Target

9 Followers
See the Price Targets and Ratings of:

0O59 Analyst Ratings

Moderate Buy
13Ratings
9 Buy
3 Hold
1 Sell
Based on 13 analysts giving stock ratings to
Sanofi
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0O59 Stock 12 Month Forecast

Average Price Target

€112.34
▲(22.43% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Sanofi in the last 3 months. The average price target is €112.34 with a high forecast of €130.00 and a low forecast of €85.00. The average price target represents a 22.43% change from the last price of €91.76.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"81":"€81","106":"€106","131":"€131","93.5":"€93.5","118.5":"€118.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":130.000000298259,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€130.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":112.33777,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€112.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":85.0000001950155,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€85.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[81,93.5,106,118.5,131],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2024","6":"May<br/>2024","9":"Aug<br/>2024","12":"Nov<br/>2024","25":"Nov<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,98.728,101.13353848448146,103.53907696896292,105.94461545344438,108.35015393792585,110.75569242240731,113.16123090688878,115.56676939137023,117.9723078758517,120.37784636033317,122.78338484481462,125.18892332929609,127.59446181377754,{"y":130.000000298259,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,98.728,99.77490538461538,100.82181076923077,101.86871615384615,102.91562153846154,103.96252692307692,105.00943230769231,106.0563376923077,107.10324307692308,108.15014846153846,109.19705384615385,110.24395923076924,111.29086461538462,{"y":112.33777,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,98.728,97.67200001500119,96.61600003000238,95.56000004500358,94.50400006000477,93.44800007500596,92.39200009000714,91.33600010500834,90.28000012000953,89.22400013501073,88.16800015001192,87.11200016501311,86.05600018001431,{"y":85.0000001950155,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":82.462,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":82.462,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.766,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.254,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.925,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.876,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.785,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.104,"date":1720137600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.594,"date":1722556800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.329,"date":1725580800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.752,"date":1728000000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.728,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€130.00Average Price Target€112.34Lowest Price Target€85.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus
€111€123
Buy
34.05%
Upside
Reiterated
09/24/24
Sanofi's Promising Portfolio Drives Buy Rating Amid MS, Cancer Breakthroughs, and Vaccine Expansion
Barclays
€105€120
Buy
30.78%
Upside
Reiterated
09/23/24
Sanofi (SNYNF) Receives a Buy from Barclays
Citi
€125€130
Buy
41.68%
Upside
Reiterated
09/16/24
Sanofi (SAN:FP) (SNY) PT Raised to EUR130 at Citi, sees 'a highly attractive risk-reward'Citi analyst Peter Verdult raised the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR130.00 (from EUR125.00) while maintaining a Buy rating.
Guggenheim
€118€125
Buy
36.23%
Upside
Reiterated
07/11/24
Sanofi price target raised to EUR 125 from EUR 118 at GuggenheimSanofi price target raised to EUR 125 from EUR 118 at Guggenheim
Morgan Stanley
€52.36
Hold
-42.94%
Downside
Reiterated
01/23/24
Morgan Stanley starts Sanofi-Aventis (SNY) at EqualweightMorgan Stanley analyst Mark Purcell initiates coverage on Sanofi-Aventis (NASDAQ: SNY) with a Equalweight rating and a price target of $55.00.

Best Analysts Covering Sanofi

Which Analyst Should I Follow If I Want to Buy GB:0O59 and Sell After:
1 Month
xxx
Success Rate
12/20 ratings generated profit
60%
Average Return
+0.76%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +0.76% per trade.
3 Months
xxx
Success Rate
24/38 ratings generated profit
63%
Average Return
+2.01%
assigned a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 63.16% of your transactions generating a profit, with an average return of +2.01% per trade.
1 Year
Peter WelfordJefferies
Success Rate
26/38 ratings generated profit
68%
Average Return
+3.78%
assigned a buy rating last month
Copying Peter Welford's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +3.78% per trade.
2 Years
xxx
Success Rate
34/45 ratings generated profit
76%
Average Return
+5.23%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 75.56% of your transactions generating a profit, with an average return of +5.23% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0O59 Analyst Recommendation Trends

Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
0
0
0
0
0
Buy
17
25
23
23
11
Hold
10
10
10
8
7
Sell
4
5
6
5
4
Strong Sell
0
0
0
0
0
total
31
40
39
36
22
In the current month, 0O59 has received 11 Buy Ratings, 7 Hold Ratings, and 4 Sell Ratings. 0O59 average Analyst price target in the past 3 months is €112.34.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

0O59 Financial Forecast

0O59 Earnings Forecast

Next quarter’s earnings estimate for 0O59 is €1.61 with a range of €1.36 to €1.79. The previous quarter’s EPS was €2.86. 0O59 beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 42.55% of the time in the same period. In the last calendar year 0O59 has Outperformed its overall industry.
Next quarter’s earnings estimate for 0O59 is €1.61 with a range of €1.36 to €1.79. The previous quarter’s EPS was €2.86. 0O59 beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 42.55% of the time in the same period. In the last calendar year 0O59 has Outperformed its overall industry.

0O59 Sales Forecast

Next quarter’s sales forecast for 0O59 is €12.12B with a range of €11.57B to €12.65B. The previous quarter’s sales results were ―. 0O59 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 44.44% of the time in the same period. In the last calendar year 0O59 has Outperformed its overall industry.
Next quarter’s sales forecast for 0O59 is €12.12B with a range of €11.57B to €12.65B. The previous quarter’s sales results were ―. 0O59 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 44.44% of the time in the same period. In the last calendar year 0O59 has Outperformed its overall industry.

0O59 Stock Forecast FAQ

What is GB:0O59’s average 12-month price target, according to analysts?
Based on analyst ratings, Sanofi’s 12-month average price target is €112.34.
    What is GB:0O59’s upside potential, based on the analysts’ average price target?
    Sanofi has 22.43% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Sanofi a Buy, Sell or Hold?
          Sanofi has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 3 hold ratings and 1 sell ratings.
            What is Sanofi’s share price target?
            The average share price target for Sanofi is €112.34. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €130.00 ,and the lowest forecast is €85.00. The average share price target represents 22.43% Increase from the current price of €91.759.
              What do analysts say about Sanofi?
              Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of Sanofi?
                To buy shares of GB:0O59, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis